VISA, Hetero-VISA and VRSA: The End of the Vancomycin Era?

dc.contributor.authorConly, John M
dc.contributor.authorJohnston, B Lynn
dc.date.accessioned2018-09-27T12:24:22Z
dc.date.available2018-09-27T12:24:22Z
dc.date.issued2002-01-01
dc.date.updated2018-09-27T12:24:21Z
dc.description.versionPeer Reviewed
dc.identifier.citationJohn M Conly and B Lynn Johnston, “VISA, Hetero-VISA and VRSA: The End of the Vancomycin Era?,” Canadian Journal of Infectious Diseases, vol. 13, no. 5, pp. 282-284, 2002. doi:10.1155/2002/245109
dc.identifier.doihttps://doi.org/10.1155/2002/245109
dc.identifier.urihttp://hdl.handle.net/1880/108601
dc.identifier.urihttps://doi.org/10.11575/PRISM/45222
dc.language.rfc3066en
dc.rights.holderCopyright © 2002 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
dc.titleVISA, Hetero-VISA and VRSA: The End of the Vancomycin Era?
dc.typeJournal Article
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
CJIDMM.2002.245109.pdf
Size:
64.74 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description: